Moderna, Gandeeva ink pact to research on protein surface structure
Maddie Meyer/Getty Images News                 

Moderna (NASDAQ:MRNA) is collaborating withÂ Gandeeva TherapeuticsÂ to explore protein surface structure at atomic resolution.
Under the research agreement, the companies will study and validate the application of Gandeeva's AI-enabledÂ cryogenic electron microscopy (cryo-EM) platform approach for an undisclosed Moderna target.
Gandeeva will get research payments from Moderna.
Additional terms were not disclosed.
"Through our internal pipeline programs and collaborations, we are aggressively pursuing the development of first-in-class modalities in targeting difficult-to-drug protein-protein interactions," saidÂ Gandeeva Founder and CEOÂ Sriram Subramaniam.